Viewing nowCombinationCeviruka HCT Tablet 5/20/12.5 mg
Amlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 201904428 · Approved 2019.06.27 · Insurance code 694004370
Improvement of blood pressure control in essential hypertension
The combination therapy of amlodipine and olmesartan medoxomil helps patients with essential hypertension who have difficulty in controlling blood pressure. These medications work to dilate blood vessels, reducing blood pressure and lowering the burden on the heart. The combined effect is superior to single agent therapy, contributing to a reduced risk of complications from hypertension. Therefore, continuous usage and consultation with healthcare professionals are essential for stable blood pressure management. This therapy effectively improves essential hypertension.
The recommended dosage is 1 tablet once daily, taken with water regardless of meals. If possible, take it at the same time every day (e.g., in the morning). The dosage may be adjusted according to the patient's blood pressure response, with adjustments made at intervals of more than 2 weeks. The maximum dosage is 10/40/25 mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. The recommended dosage stages are as follows: - 5/20/12.5 mg: Amlodipine
Safety and efficacy for pediatric patients under 18 years of age have not been established, and therefore the use of this medication is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Do not use in patients with a known allergy to this medication or its components, or in those with specific heart diseases, severe kidney and liver diseases, or in pregnant or nursing women. Patients with low blood volume or reduced salt may experience hypotension when starting this medication, so their condition should be closely monitored. Caution is advised for patients with unstable kidney function, kidney transplant recipients, and those with renovascular hypertension, as well as for patients with liver disease. This medication lowers blood pressure, so patients undergoing hypertension treatment should monitor their blood pressure to prevent it from becoming too low. Dizziness or drowsiness may occur while taking this medication, so it is advisable to avoid driving or operating hazardous machinery. If allergic symptoms such as unusual rashes, itching, or breathing difficulties occur during treatment, consult a doctor immediately. This medication can cause electrolyte imbalances in some patients, so regular blood tests to check potassium, sodium, etc., are necessary. Interactions may occur when taken with other medications, so inform your healthcare provider of any other medications you are taking. In cases of overdose, hypotension, and heart rhythm disturbances may occur, so dosage should be strictly adhered to, and medical attention should be sought if any abnormal symptoms appear. This medication is not recommended for children due to insufficient safety and efficacy data. In elderly patients, due to potential decreased kidney function, medication response may vary, so it is recommended to start with a low dose and administer cautiously. Store this medication out of reach of children and keep it in a tightly closed container, avoiding moisture and direct sunlight.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, cough with fever accompanied by respiratory abnormalities, yellowing of skin or eyes (jaundice), profound lethargy, sudden and very severe headache, thunderclap headache, seizures, confusion, vision abnormalities, paralysis, urine changes
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This helps to preserve the medication’s effectiveness.
White and orange round film-coated tablet
28 tablets (14 tablets/PTP X 2)/carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.